Clinical Trials · NCT04129255
Octreotide LAR in the Induction of Immunologic Response in NENs Patients
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- National Cancer Institute, Naples
- Enrollment
- 34
- Start date
- Jun 2017
- Locations
- 1 site, Italy
- Primary endpoint
- Exploring the changes in immune-regulatory cells induced by OCT LAR